Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,760 results for "Product Liability Law & Strategy"...

Court Watch
October 02, 2013
The Instrumentality Test For Determining Franchisor Vicarious Liability
Considerations When Engaging in Internet Marketing
October 02, 2013
In this day and age, most law firms have a website and use the Internet as a large part of their overall marketing scheme. However, the ethical considerations are plentiful and not always clear-cut. Even if your firm utilizes a Web developer or marketing firm, it is ultimately the lawyer's responsibility to ensure that his or her Internet marketing is compliant with the applicable rules of professional conduct and state law.
Spotlight on 3D Printing: Intellectual Property
September 30, 2013
3D printing technology, also known as additive manufacturing, is nothing new. It has been used for decades by designers and engineers. But the technical capabilities that make 3D printing technologies so useful likely will facilitate intellectual property infringement.
Case Notes
September 26, 2013
Discussion of a Flonase class action ruling.
PA Court Ignored SCOTUS in Reglan Ruling
September 26, 2013
The PA Superior Court's recent decision not to apply blanket pre-emption to failure-to-warn claims against the makers of the generic version of drug Reglan ignores U.S. Supreme Court precedent ...
Practice Tip: Explosion and Fire Litigation
September 26, 2013
The spectrum of challenges inherent in fire and explosion litigation can and should stimulate creative responses. One size does not fit all.
State-Law Design-Defect Claims Against Generic Drug Manufacturers Are Preempted
September 26, 2013
This article discusses <I>Mensing</I> and <I>Bartlett</I> and their potential impact.
Relearning the Learned Intermediary Doctrine
September 25, 2013
Courts in nearly every state have embraced some form of the "learned intermediary doctrine," which provides that a prescription drug manufacturer satisfies its duty to warn so long as it provides an adequate warning of the drug's potential risks to the plaintiff's prescribing doctor.
Insurance Claims for Solar Panel Defects
September 24, 2013
Recent reports of a quality crisis in the solar panel industry, following years of exploding growth and intense price pressure, have raised the specter of a wave of litigation.
Your Business: Someone Online Hates You
September 02, 2013
As word of mouth moves online, lawyers occupy the same place today that hotels were in a decade ago: just starting to face the prospect of widespread use of online user reviews, and concerned that such reviews will crater their businesses. The following 10 tips will put these concerns into context and explore which methods of responding to negative feedback are effective and ethical and which ones aren't.

MOST POPULAR STORIES

  • Private Equity Valuation: A Significant Decision
    Insiders (and others) in the private equity business are accustomed to seeing a good deal of discussion ' academic and trade ' on the question of the appropriate methods of valuing private equity positions and securities which are otherwise illiquid. An interesting recent decision in the Southern District has been brought to our attention. The case is <i>In Re Allied Capital Corp.</i>, CCH Fed. SEC L. Rep. 92411 (US DC, S.D.N.Y., Apr. 25, 2003). Judge Lynch's decision is well written, the Judge reviewing a motion to dismiss by a business development company, Allied Capital, against a strike suit claiming that Allied's method of valuing its portfolio failed adequately to account for i) conditions at the companies themselves and ii) market conditions. The complaint appears to be, as is often the case, slap dash, content to point out that Allied revalued some of its positions, marking them down for a variety of reasons, and the stock price went down - all this, in the view of plaintiff's counsel, amounting to violations of Rule 10b-5.
    Read More ›